Austria vs Kiribati: The number of people with susceptibility test result for rifampicin
Austria
165
in 2021
Kiribati
177
in 2021
Austria rank
98th
Kiribati rank
96th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Kiribati
How they compare
Kiribati currently reports 177 against 165 in Austria, a difference of 12.
That makes Kiribati's figure about 1.1 times Austria's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Austria ahead.
Austria ranks 98th and Kiribati ranks 96th of 155 countries.
Across the 2 decades both report, Austria averaged higher in 1 and Kiribati in 1.
Head to head by decade
| Decade | Austria | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 220.67 | 115.67 | 105 | Austria |
| 2020s | 169 | 175.5 | 6.5 | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Kiribati?
- Kiribati, at 177 against 165 in Austria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Kiribati?
- 12, with Kiribati ahead.
- How many years of comparable data are there for Austria and Kiribati?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Kiribati rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 98th and Kiribati ranks 96th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.